Chronic Liver Disease

Measuring Patient Reported Needs in Outpatient Liver Disease Management

Study on the Efficacy and Safety of Avatricopal in Patients With CLD Complicated With Thrombocytopenia

Effect of Ursodeoxycholic Acid Supplementation on Liver Regeneration in Adult Living Donor Liver Transplant (LDLT) Recipients.

Referral of Patients to Hepatology With Hepatoscope

EUS vs TJ for Liver Biopsy and Portal Pressure Gradient Measurement

Increlex Treatment of Children With Chronic Liver Disease and Short Stature

Copper Supplementation in Cirrhosis

FAST-IRM for HCC suRveillance in pAtients With High risK of Liver Cancer.

An Observational Study of Patients With Chronic Liver Disease

In Patients With Chronic Liver Diseases(Alcoholic Liver Disease and Non-Alcoholic Fatty Liver Disease), LAENNEC(Human Placenta Hydrolysate) is to Evaluate the Efficacy and Safety of Intravenous Drop

Part A: In Patients With Chronic Liver Diseases, LAENNEC (Human Placenta Hydrolysate) is to Assess Safety and Tolerability After the Doses of Doses. Part B: Part A, it is to Determine the Optimal Dose by Evaluating Two Capacity and Placebo Groups.

Liver and Splenic Stiffness in Predicting Esophageal Varices Needing Treatment in MASLD Related Compensated Advanced Chronic Liver Disease.

To Study the Clinical Course and Outcomes of Non-electively Hospitalised Patients of Chronic Liver Disease (CLD) With Hepatic or Extra-hepatic Predominant Organ Failure(s) at 6 Months.

Endoscopic Ultrasound Shear Wave Elastography Study

Comparison of the Acute Effects of Chest Physiotherapy Methods Applied in Different Positions in Preterm Newborns

hepatomiR cACLD Study

VIATORR Device Registry

Comparing Portal Vein Assessment by Intraoperative Doppler and Transesophageal Echocardiography

Mobile Chat Messaging for Alcohol Reduction in Patients With Chronic Liver Diseases

The SHUNT-V Study for Varices